A shift in how IoT is secured by default

Tern plc

The release of KeyScaler 2025 marks a transformational moment for organisations wrestling with sprawling IoT and OT device estates. Rather than accepting the traditional burden of manual certificate issuance, policy definition and certificate revocation across thousands or even millions of devices, KeyScaler 2025 introduces a fully automated, AI‑driven trust lifecycle.

Manual processes have long been the Achilles’ heel of large‑scale deployments, introducing delays, human error and security gaps. By embedding AI that continuously monitors device behaviour, identity attributes and compliance posture, KeyScaler 2025 is designed to detect anomalies and potential threats in real time, and to trigger remediation automatically.

The platform incorporates a ‘Policy Intelligence Engine’ that enforces zero‑trust principles dynamically, adapts permissions based on contextual threat data and ensures data exchanges remain encrypted and auditable. For industries such as manufacturing, healthcare, energy or logistics, these features offer critical assurances.

Tern plc (LON:TERN) backs exciting, high growth IoT innovators in Europe. They provide support and create a genuinely collaborative environment for talented, well-motivated teams.

Share on:
Find more news, interviews, share price & company profile here for:

Latest Company News

Fundamental XR expands access to immersive training with web-enabled platform

Its new Immersive Web platform brings immersive training into the browser, lowering adoption barriers and broadening enterprise reach.

GLP-1 receptor agonists: Strategic market shift

Rapid uptake, evolving regulation and digital integration are reshaping the investment case for metabolic health therapies.

The Cyber Resilience Act forces a security reset for connected device makers

Device Authority helps manufacturers operationalise Cyber Resilience Act compliance through automated device identity and secure update management.

Pharmaceutical groups move closer to the consumer in strategic marketing reset

Pharmaceutical marketing is shifting towards direct consumer engagement, reshaping how companies compete and manage risk in a digital environment.

Changing clinician behaviour reshapes commercial strategy for 2026

As clinician engagement becomes more digital and measurable, companies that act on behavioural data can improve targeting, reduce risk and strengthen competitive positioning in 2026.

Tern Plc launches £384,408 Open Offer at 0.40p per share

Tern Plc has announced an Open Offer to raise up to £384,408 through the issue of up to 96,101,957 shares at 0.40p each, a 20% discount to the 12 February 2026 closing price.

Search

Search